PDF (Español (España))
FLIP
EPUB (Español (España))
HTML (Español (España))
XML (Español (España))
Manuscripts sent to SALUTA Magazine must be original and unpublished and must not be simultaneously in the process of publication in other magazines, compilations or any other means of publication. The content of the publications and the links suggested in them are the sole responsibility of the authors and not of the METROPOLITAN UNIVERSITY OF EDUCATION, SCIENCE AND TECHNOLOGY
(UMECIT) or the magazine SALUTA. They are protected by international copyright laws as well as the logos of UMECIT AND SALUTA MAGAZINE, hence their reproduction is totally prohibited. The copyright will belong to the UMECIT.
Under a Creative Commons Attribution License authors may share work with acknowledgment of authorship of the work and initial publication in this journal.
Abstract
The present research entitled “Covid 19: Relevance of Rapid Antigenic Tests for Its Diagnosis”, aims to know the importance of the use of rapid diagnostic tests during the Covid-19 pandemic. A descriptive theoretical work of a documentary type is carried out, based on technical documents of the World Health Organization on the detection of antigen for SarCov-2 and scientific articles published from international sources in Spanish and English from 2019 to 2021, indexed in different databases. In the search strategy, different descriptors were used combining words and Boléan operators used were intersection (AND), to establish the logical operations between the concepts and (OR) to retrieve documents where one, another or at least one of the arguments appears. In addition, the Zotero manager was used. Eight articles were selected and a content analysis was performed. The study highlights among its results information on the type of test, sensitivity, specificity, use, type of patients, predictive values; sensitivity and specificity were evaluated, where it was determined that the Abbott BinaxNow and Panbio; with sensitivities of 93.9%, 93.3% and 82.1% respectively. Predictive values between 50-100% were obtained for different types of samples and different methodologies. Despite what the literature maintains, acceptable sensitivities were obtained, regardless of the place where the sample was taken, whether it was nasopharyngeal as recommended by various studies or nasal, which offers an advantage in pediatric patients and those who present some type of previous disease in the upper airways.
References
Almonacid Urrego, C. C., Giratá Pedraza, M. V., Salcedo Pretelt, I., & Almonacid Urrego, I. C. (2020). Papel de las pruebas rápidas (POCT) en el diagnóstico del SARS-COV-2, agente causal de COVID-19. Nova, 18(35), 43–52. https://doi.org/10.22490/24629448.4185
Chamorro, M. J. M., & Onoda, M. (2020). Pruebas diagnósticas de SARS-CoV-2. 9.
Dinnes, J., Deeks, J. J., Berhane, S., Taylor, M., Adriano, A., Davenport, C., Dittrich, S., Emperador, D., Takwoingi, Y., Cunningham, J., Beese, S., Domen, J., Dretzke, J., Ferrante di Ruffano, L., Harris, I. M., Price, M. J., Taylor-Phillips, S., Hooft, L., Leeflang, M. M., … Cochrane COVID-19 Diagnostic Test Accuracy Group. (2021). Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD013705.pub2
Gámiz, F., Sampedro, C., Navarro, C., Salazar, N., Donetti, L., Márquez, C., Luis, J., Medina, C., & Galdón, J. C. (2020). Detection of COVID-19 disease using graphene-based biosensors. 10.
García, C. D., Arias, J. V., & Marval, L. E. (s/f). PRUEBAS ANTIGÉNICAS EN LA VIGILANCIA EPIDEMIOLÓGICA DE COVID-19. 23, 16.
Landaas, E. T., Storm, M. L., Tollånes, M. C., Barlinn, R., Kran, A.-M. B., Bragstad, K., Christensen, A., & Andreassen, T. (2021). Diagnostic performance of a SARS-CoV-2 rapid antigen test in a large, Norwegian cohort. Journal of Clinical Virology, 137, 104789. https://doi.org/10.1016/j.jcv.2021.104789
Mojica-Crespo, R., & Morales-Crespo, M. M. (2020). Pandemia COVID-19, la nueva emergencia sanitaria de preocupación internacional: Una revisión. Medicina de Familia. SEMERGEN, 46, 65–77. https://doi.org/10.1016/j.semerg.2020.05.010
Muñoz, W. A., Fuentes, D. B., & Urzúa, M. J. F. (2021). Rol de los laboratorios públicos en el diagnóstico SARS-CoV-2 en la pandemia de COVID-19: Experiencia, desafíos y oportunidades. Revista Chilena de Infectología, 38(2), Article 2. https://www.revinf.cl/index.php/revinf/article/view/1051
NCoVsitrep30Jan2020-eng.pdf. (s/f). Recuperado el 7 de julio de 2021, de https://apps.who.int/iris/bitstream/handle/10665/330775/nCoVsitrep30Jan2020-eng.pdf?sequence=1&isAllowed=y
OMS. (2020). Consejos sobre el uso de pruebas de inmunodiagnóstico en el lugar de atención para COVID-19 [Informativa]. Consejos sobre el uso de pruebas de inmunodiagnóstico en el lugar de atención para COVID-19. https://www.who.int/news-room/commentaries/detail/advice-on-the-use-of-point-of-care-immunodiagnostic-tests-for-covid-19
OPSIMSPHECOVID-19200038_spa.pdf. (s/f). Recuperado el 9 de noviembre de 2021, de https://iris.paho.org/bitstream/handle/10665.2/52471/OPSIMSPHECOVID-19200038_spa.pdf?sequence=1&isAllowed=y
PCR-en-tiempo-real.pdf. (s/f). Recuperado el 5 de julio de 2021, de https://www.researchgate.net/profile/Martha-Eugenia-Ruiz-Tachiquin/publication/259042551_PCR_en_tiempo_real/links/53d119740cf2fd75bc5d725e/PCR-en-tiempo-real.pdf
Pita Fernández, S., Pértegas Díaz, S. (2010, diciembre 7). Pruebas diagnósticas: Sensibilidad y especificidad. [Guías Clínicas]. Pruebas diagnósticas: Sensibilidad y especificidad. https://www.fisterra.com/mbe/investiga/pruebas_diagnosticas/pruebas_diagnosticas.asp
R&D Blue Print. (2021). Rastreador de vacunas COVID-19 y paisaje. World Health Organization. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines
Valencia Portillo, R. T., Amorín Uscata, B., Gonzales-Zubiate, F. A., Juscamaita Medina, K., Sevillano, O. R., & Ramos-Sanchez, E. M. (2020). Pruebas rápidas para COVID-19, la mejor alternativa para Ecuador. Bionatura, 5(3), 1280–1283. https://doi.org/10.21931/RB/2020.05.03.21
WHO-2019-nCoV-Antigen_Detection-2020.1-eng.pdf. (s/f). Recuperado el 5 de julio de 2021, de https://apps.who.int/iris/bitstream/handle/10665/334253/WHO-2019-nCoV-Antigen_Detection-2020.1-eng.pdf?sequence=1&isAllowed=y
WHO-2019-nCoV-Antigen_Detection-2020.1-spa.pdf. (s/f-a). Recuperado el 7 de julio de 2021, de https://apps.who.int/iris/bitstream/handle/10665/336028/WHO-2019-nCoV-Antigen_Detection-2020.1-spa.pdf?sequence=1&isAllowed=y'>https://apps.who.int/iris/bitstream/handle/10665/336028/WHO-2019-nCoV-Antigen_Detection-2020.1-spa.pdf?sequence=1&isAllowed=y
WHO-2019-nCoV-Antigen_Detection-2020.1-spa.pdf. (s/f-b). Recuperado el 7 de julio de 2021, de https://apps.who.int/iris/bitstream/handle/10665/336028/WHO-2019-nCoV-Antigen_Detection-2020.1-spa.pdf?sequence=1&isAllowed=y'>https://apps.who.int/iris/bitstream/handle/10665/336028/WHO-2019-nCoV-Antigen_Detection-2020.1-spa.pdf?sequence=1&isAllowed=y
WHO-2019-nCoV-laboratory-2020.6-eng.pdf. (s/f). Recuperado el 7 de julio de 2021, de https://apps.who.int/iris/bitstream/handle/10665/334254/WHO-2019-nCoV-laboratory-2020.6-eng.pdf?sequence=1&isAllowed=y
Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., Hoelscher, M., Bleicker, T., Brünink, S., Schneider, J., Ehmann, R., Zwirglmaier, K., Drosten, C., & Wendtner, C. (2020). Virological assessment of hospitalized patients with COVID-2019. Nature, 581(7809), 465–469. https://doi.org/10.1038/s41586-020-2196-x
